Independent research Source-backed profiles No paid rankings
Peptide Provider Direct
RegenesisMD logo
Unclaimed12 services cataloged

RegenesisMD

Raleigh, NC · Telehealth available

Visit provider website ↗

Provider overview

About RegenesisMD

RegenesisMD publishes a North Raleigh clinic address and identifies Bhavna Vaidya, MD, as founder and medical director. Its official peptide page explicitly describes peptide therapies as compounded, investigational and/or off-label, and not FDA-approved for the promoted indications. Telehealth is limited on the reviewed source to follow-up for established patients in North Carolina.

At a glance

Market role
Direct patient-care provider
Care model
Telehealth and In person
Coverage
1 listed jurisdictions
Pharmacy pathway
Not publicly established

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Provider-advertised services, grouped for quick scanning with all details visible.

12 cataloged
01

Provider-advertised recovery peptides

2

BPC-157

RegenesisMD advertises BPC-157 within supervised recovery-oriented protocols and labels its peptide therapies investigational or off-label.

Provider source ↗

TB-500

TB-500 is named in the clinic's public peptide catalog; inclusion does not establish approval, safety, or effectiveness.

Provider source ↗
02

Provider-advertised growth-hormone peptides

2

Sermorelin

Sermorelin is listed in a provider-supervised growth-hormone optimization pathway.

Provider source ↗

CJC-1295 / Ipamorelin

The combination is named in the clinic's public peptide materials and remains subject to clinical screening.

Provider source ↗
03

Provider-advertised metabolic peptides

2

MOTS-C

MOTS-C is listed in the clinic's metabolic peptide catalog without implying regulatory approval or expected results.

Provider source ↗

Tesamorelin blends

The clinic advertises tesamorelin-related blends; approved indications must not be generalized to advertised uses.

Provider source ↗
04

Metabolic health

1

Semaglutide and tirzepatide programs

Physician-supervised GLP-1 and GIP/GLP-1 weight-management pathways are listed with ongoing monitoring.

Provider source ↗
05

Infusion services

1

NAD+ IV therapy

NAD+ IV therapy is advertised at the Raleigh clinic as part of its wellness catalog.

Provider source ↗
06

Hormone health

1

Hormone optimization

BHRT and testosterone optimization are listed as lab-guided services for women and men.

Provider source ↗
07

Testing and ongoing care

2

Functional-medicine laboratory testing

The clinic advertises advanced lab work and health screening to inform individualized planning.

Provider source ↗

Established-patient telehealth follow-up

Telehealth follow-ups are explicitly described for established patients throughout North Carolina.

Provider source ↗
08

Regenerative care

1

PRP, stem-cell, and joint procedures

The clinic advertises PRP, joint injections, and stem-cell-related services while noting investigational status for orthopedic stem-cell use.

Provider source ↗
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Coverage and research

Explore this provider’s markets

Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.

Continue comparing

Related provider profiles

Evidence

Sources reviewed

Logo reproduced from the provider’s official website for identification. Logo source ↗

These links support the public facts recorded here. Provider-published information is not an independent endorsement.